Insider Transactions Reported by 18 Insiders of REGENXBIO Inc.

Symbol
RGNX on Nasdaq
Location
Rockville, MD

Insiders trading volume in the past year

REGENXBIO Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Allan M. Fox Director $23,125,113 30 May 2025
Curran Simpson Chief Executive Officer, Director $4,931,559 -$416,598 -7.8% 06 Jan 2026
Kenneth T. Mills Director $3,848,481 -$163,046 -4.1% 30 May 2025
STEVE PAKOLA Chief Medical Officer $3,719,790 06 Jan 2026
Patrick J. Christmas Chief Strategy & Legal Officer $3,101,306 06 Jan 2026
Mitchell Chan Chief Financial Officer $1,839,137 06 Jan 2026
Olivier Danos Chief Scientific Officer $1,826,628 01 Feb 2025
Craig Malzahn Chief Technology Officer $1,183,601 06 Jan 2026
Vittal Vasista Chief Financial Officer $926,968 19 Mar 2024
Jennifer Zachary Director $175,850 30 May 2025
Alexandra Glucksmann Director $151,860 30 May 2025
Jean Bennett Director $151,860 30 May 2025
GEORGE MIGAUSKY V. Director $151,860 30 May 2025
ARGERIS N. KARABELAS Director $151,860 30 May 2025
DAVID C. STUMP Director $151,860 30 May 2025
Daniel Tasse Director $151,860 30 May 2025
Daniel Abdun-Nabi Director 04 Jun 2021
LUKE M. BESHAR Director 04 Jun 2021

Recent Insider Transactions by Companies or Individuals for REGENXBIO Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.